Organization Description
Healthspan Capital is a venture capital firm with a mission to broadly invest and support longevity biotechnology (“LongBio”) companies developing therapeutics to extend healthy human lifespan. They believe that rejuvenation biotechnology is the future of medicine.
Healthspan Capital was founded in 2021 by Sebastian Brunemeier, Nathan Cheng, and Michael Chinen. Their fund was the first publicly accessible longevity venture fund listed on Angel List.
Team
